BioCentury
ARTICLE | Financial News

Lexicon completes rights offering

January 2, 2012 8:00 AM UTC

Lexicon Pharmaceuticals Inc. (NASDAQ:LXRX), The Woodlands, Texas Business: Gastrointestinal, Autoimmune, Functional genomics Date completed: 12/23/11 Type: Rights offering Raised: $161 million Shares:...